The InPen is the only FDA-cleared smart†† insulin pen that combines the freedom of Bluetooth® technology and intelligence through an easy to use smartphone app, helping people administer correction and mealtime insulin doses.
Better diabetes technology for you
The InPen smart insulin pen works with a continuous glucose monitor (CGM) to make managing diabetes easier. It helps:
It’s time you ask more of your diabetes technology and let it do more of the work for you.
The pen
Pay as little as $60* per year for the InPen
We don't want cost to be a roadblock to you getting the therapy you need. With the InPenTM access program, you could pay as little as $60 per year.
*Offer is available to people with commercial insurance. Terms and conditions apply.
What is the InPen?
The InPen is the only FDA-cleared smart†† insulin pen that combines the freedom of Bluetooth® technology and intelligence through an easy to use smartphone app, helping people administer correction and mealtime insulin doses.
How much does InPen cost?
InPen is a prescription-only device. Eligible patients with commercial insurance may pay as little as $60 per prescribed InPen. Each InPen is reusable for one year. Terms and conditions apply.
Are insulin cartridges included?
Cartridges are not included with InPen. You’ll need a separate prescription for cartridges. Cartridges can be ordered from the same pharmacy where you get your other diabetes supplies. InPen is compatible with Humalog, Novolog and Fiasp U-100 3.0 mL insulin cartridges.
Does InPen work with long-acting insulin?
The InPen app allows you to manually log your long-acting insulin doses and set up dose reminders to take your long-acting insulin. InPen works with the following short-acting insulins: Novolog, Humalog, and Fiasp.
Can I pair more than one InPen to the app?
Yes, you can pair as many InPens as you need to the app. This enables the flexibility for you to have one InPen at home and another at work or school.
Note: Make sure your paired device is within range of your InPen when you dose. Your InPen app will automatically sync doses from all paired InPen(s) when within range.
References
† Compatible smart phone, connectivity, proper settings, and accurate and timely logging of all insulin doses from all sources required. See user guide for complete details.
‡ Data may not appear or be delayed in certain instances, including when there is no internet connection.
§ Humalog® is a registered trademarks of Eli Lilly and Company. Fiasp® and Novolog® are registered trademarks of Novo Nordisk A/S.
Ω Based on 150 injections per month versus 10 insertions per month.
†† Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.
Prescription required
Each InPen is reusable for one year. Offer available to eligible patients with commercial insurance. Terms and conditions apply.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
Important Safety Information: InPen system
The InPen system consists of a reusable insulin pen and mobile app and is for people living with diabetes. It can be used to deliver insulin, help calculate insulin doses, and estimate carbohydrates for meals. Those under the age of 7 should only use the device with an adult’s supervision. A healthcare provider must prescribe InPen, provide dosage settings, and discuss all potential benefits and risks. Using the device with incorrect therapy settings may lead to severe highs and lows. The system should not be used by those unable to test blood glucose levels or the visually impaired. For additional safety information and user guides, see https://bit.ly/MiniMedRisks.